Pursuant to Regulation 30(6) read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Sai Parenteral’s has informed that the Company has issued a Press Release titled ‘Sai Parenterals’ Wholly Owned Subsidiary SP Analytics enters an agreement to Acquire Majority Stake in Bion Therapeutics’ Prescription Business’.
The above information is a part of company’s filings submitted to BSE.